Torsemide Patent Expiration
Torsemide was first introduced by Norvium Bioscience Llc
Torsemide Patents
Given below is the list of patents protecting Torsemide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Soaanz | US10154963 | Controlled-release formulations comprising Torsemide | Oct 06, 2033 | Sarfe Pharms |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Torsemide's patents.
Latest Legal Activities on Torsemide's Patents
Given below is the list recent legal activities going on the following patents of Torsemide.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 17 Aug, 2022 | US10154963 |
| Surcharge for late Payment, Small Entity | 17 Aug, 2022 | US10154963 |
| Maintenance Fee Reminder Mailed Critical | 08 Aug, 2022 | US10154963 |
| Change in Power of Attorney (May Include Associate POA) Critical | 17 Sep, 2021 | US10154963 |
| Correspondence Address Change Critical | 15 Sep, 2021 | US10154963 |
| Patent Issue Date Used in PTA Calculation Critical | 18 Dec, 2018 | US10154963 |
| Recordation of Patent Grant Mailed Critical | 18 Dec, 2018 | US10154963 |
| Email Notification Critical | 29 Nov, 2018 | US10154963 |
| Issue Notification Mailed Critical | 28 Nov, 2018 | US10154963 |
| Dispatch to FDC | 14 Nov, 2018 | US10154963 |
Torsemide's Family Patents
Explore Our Curated Drug Screens
Torsemide Generic API Manufacturers
Several generic applications have been filed for Torsemide. The first generic version for Torsemide was by Teva Pharmaceuticals Usa Inc and was approved on May 14, 2002. And the latest generic version is by Strides Pharma Global Pte Ltd and was approved on Mar 22, 2011.
Given below is the list of companies who have filed for Torsemide generic, along with the locations of their manufacturing plants worldwide.
1. AM REGENT
American Regent Inc has filed for 2 different strengths of generic version for Torsemide. Given below are the details of the strengths of this generic introduced by Am Regent.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG/2ML (10MG/ML) | solution | Discontinued | INTRAVENOUS | N/A | Apr 21, 2010 |
| 50MG/5ML (10MG/ML) | solution | Discontinued | INTRAVENOUS | N/A | Apr 21, 2010 |
2. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 4 different strengths of generic version for Torsemide. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Prescription | ORAL | AB | Oct 17, 2007 |
| 100MG | tablet | Prescription | ORAL | AB | Oct 17, 2007 |
| 5MG | tablet | Prescription | ORAL | AB | Oct 17, 2007 |
| 10MG | tablet | Prescription | ORAL | AB | Oct 17, 2007 |
Manufacturing Plant Locations New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||
| United States |
| |||||||||
3. COREPHARMA
Corepharma Llc has filed for 4 different strengths of generic version for Torsemide. Given below are the details of the strengths of this generic introduced by Corepharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | May 31, 2005 |
| 10MG | tablet | Prescription | ORAL | AB | May 31, 2005 |
| 20MG | tablet | Prescription | ORAL | AB | May 31, 2005 |
| 100MG | tablet | Prescription | ORAL | AB | May 31, 2005 |
Manufacturing Plant Locations New
Corepharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Corepharma as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
4. HETERO LABS LTD III
Hetero Labs Ltd Unit Iii has filed for 4 different strengths of generic version for Torsemide. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Prescription | ORAL | AB | Jan 27, 2009 |
| 5MG | tablet | Prescription | ORAL | AB | Jan 27, 2009 |
| 20MG | tablet | Prescription | ORAL | AB | Jan 27, 2009 |
| 100MG | tablet | Prescription | ORAL | AB | Jan 27, 2009 |
5. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 5 different strengths of generic version for Torsemide. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Prescription | ORAL | AB | Mar 1, 2005 |
| 5MG | tablet | Prescription | ORAL | AB | Mar 1, 2005 |
| 20MG | tablet | Prescription | ORAL | AB | Mar 1, 2005 |
| 20MG/2ML (10MG/ML) | solution | Discontinued | INTRAVENOUS | N/A | Jun 11, 2008 |
| 50MG/5ML (10MG/ML) | solution | Discontinued | INTRAVENOUS | N/A | Jun 11, 2008 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
| Portugal |
| |||||||||
| Jordan |
| |||||||||
6. PLIVA PHARM IND
Pliva Pharmaceutical Industry Inc has filed for 4 different strengths of generic version for Torsemide. Given below are the details of the strengths of this generic introduced by Pliva Pharm Ind.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Prescription | ORAL | AB | May 30, 2003 |
| 20MG
(reference standard) | tablet | Prescription | ORAL | AB | May 30, 2003 |
| 5MG | tablet | Prescription | ORAL | AB | May 30, 2003 |
| 100MG | tablet | Prescription | ORAL | AB | Oct 19, 2004 |
7. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 4 different strengths of generic version for Torsemide. Given below are the details of the strengths of this generic introduced by Strides Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | tablet | Prescription | ORAL | AB | Mar 22, 2011 |
| 5MG | tablet | Prescription | ORAL | AB | Mar 22, 2011 |
| 10MG | tablet | Prescription | ORAL | AB | Mar 22, 2011 |
| 20MG | tablet | Prescription | ORAL | AB | Mar 22, 2011 |
Manufacturing Plant Locations New
Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| India |
| |||||
8. SUN PHARM INDS
Sun Pharmaceutical Industries Ltd has filed for 4 different strengths of generic version for Torsemide. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | tablet | Discontinued | ORAL | N/A | Feb 26, 2008 |
| 10MG | tablet | Discontinued | ORAL | N/A | Feb 26, 2008 |
| 20MG | tablet | Discontinued | ORAL | N/A | Feb 26, 2008 |
| 5MG | tablet | Discontinued | ORAL | N/A | Feb 26, 2008 |
9. TEVA
Teva Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Torsemide. Given below are the details of the strengths of this generic introduced by Teva.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Discontinued | ORAL | N/A | May 14, 2002 |
| 20MG | tablet | Discontinued | ORAL | N/A | May 14, 2002 |
| 100MG | tablet | Discontinued | ORAL | N/A | May 14, 2002 |
| 5MG | tablet | Discontinued | ORAL | N/A | May 14, 2002 |
Manufacturing Plant Locations New
Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
| India |
| |||||||||
| Canada |
| |||||||||
| Czech Republic |
| |||||||||
| Ireland |
| |||||||||
| Israel |
| |||||||||